269106 Strategies for mHealth use in surveillance and triage after a biological attack

Monday, October 29, 2012 : 1:10 PM - 1:30 PM

Daniel Basco , Science and Technology Policy Institute, Institute for Defense Analyses, Washington, DC
Over the past decade, strategies and plans have been developed at the local, state, and federal levels to respond to a biological attack. The primary public health goal of these plans is to disseminate medical countermeasures (MCM) to the public immediately after an attack to mitigate physical harm. However, these plans do not address ways to track the specific antibiotics that individuals receive nor the potential symptom onset if the initial MCMs are ineffective. This study will present the legal concerns and implementation strategies for using mobile health, otherwise known as mHealth, to collect information rapidly from the public in order to better inform secondary MCM distribution or other public health interventions in the event that drugs provided during the initial MCM distribution prove ineffective. Given the need to provide antitoxins once symptoms develop and their relative limited supply, a mHealth application could also be used to assist individuals in determining if they need to seek professional help as a first mechanism for triage. Using the case study of an antibiotic-resistant, aerosolized anthrax attack, this project will present a framework for designing and disseminating a mHealth application for use in emergency situations where multiple public health interventions may be needed.

Learning Areas:
Communication and informatics
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
Discuss the necessary components of a mHealth application for surveillance data collection and triage Describe the legal barriers to collecting health information via mHealth

Keywords: Data/Surveillance, Bioterrorism

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the primary researcher on this project and a larger project evaluating federal health information technology efforts.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.